🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

33 results for “atra” Clear

  1. Dabigatran Etexilate

    CORCEPT THERAPEUTICS INC

    Cushing Syndrome

    phase 1 small molecule completed

    1 trial

  2. Drug-Drug Interaction Study With BIA 28-6156 and Clarithromycin, Midazolam, and Dabigatran Etexilate in Healthy Participants

    BIAL - Portela & Ca

    Healthy volunteers

    phase 1 other active

    1 trial

  3. Satraplatin in combo with vinorelbine

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  4. ATRA+Arsenic

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Promyelocytic Leukemia

    approved small molecule active

    1 trial

  5. DABIGATRAN ETEXILATE , CLOPIDOGREL , RIVAROXABAN , APIXABAN , ACENOCOUMAROL , EDOXABAN

    The George Institute

    patients who are requested a colonoscopy for any indication and are under antiplatelet treatment (except ASA) or anticoagulant treatment

    approved small molecule active

    1 trial

  6. Dabigatran Etexilate

    The First People's Hospital of Lianyungang

    Atrial Fibrillation

    approved small molecule active

    1 trial

  7. Satralizumab 120 mg

    Hoffmann-La Roche

    Neuromyelitis Optica Spectrum Disorder

    approved small molecule terminated

    1 trial

  8. ATRA+Venetoclax+Azacitidine

    The First People's Hospital of Lianyungang

    AML, Adult

    small molecule active

    1 trial

  9. cisatracurium

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    ARDS

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources